Lv51
850 积分 2024-03-18 加入
Engineered exosomes: a transformative therapeutic modality
5小时前
待确认
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
4天前
已完结
Fcγ receptors and immunomodulatory antibodies in cancer
14天前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
23天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
28天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
29天前
已完结
Interleukin-2–based therapies in cancer
1个月前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
Understanding and exploiting 5T4 oncofoetal glycoprotein expression
1个月前
已完结
皖公网安备34019202002308
